1. A novel model to predict positive prostate biopsy based on serum androgen level
   Takeshi Ujike et al, 2018, Endocrine-Related Cancer CrossRef
2. TRPM8-androgen receptor association within lipid rafts promotes prostate cancer cell migration
   Guillaume P. Grolez et al, 2019, Cell Death & Disease CrossRef
3. Long-term treatment with testosterone undecanoate injections in men with hypogonadism alleviates erectile dysfunction and reduces risk of major adverse cardiovascular events, prostate cancer, and mortality
   Farid Saad et al, 2020, The Aging Male CrossRef
4. The underexplored links between cancer and the internal body climate: Implications for cancer prevention and treatment
   Doru Paul et al, 2022, Frontiers in Oncology CrossRef
5. Serum Omentin Levels in Patients with Prostate Cancer and Associations with Sex Steroids and Metabolic Syndrome
   Artur Borowski et al, 2020, Journal of Clinical Medicine CrossRef
6. Endogenous testosterone density associates with predictors of tumor upgrading and disease progression in the low through favorable intermediate prostate cancer risk categories: analysis of risk factors and clinical implications
   Antonio B. Porcaro et al, 2023, African Journal of Urology CrossRef
7. Lower baseline testosterone level is related to earlier development of castration resistance in metastatic prostate cancer: a multi-center cohort study
   Ho Ming Chris Wong et al, 2024, Frontiers in Oncology CrossRef
8. Investigating the Role of Obesity in Prostate Cancer and Identifying Biomarkers for Drug Discovery: Systems Biology and Deep Learning Approaches
   Shan-Ju Yeh et al, 2022, Molecules CrossRef
9. Evaluation of serum osteopontin and its relation with other biomarkers of prostate cancer in Iraqi patients
   Ahmad H. Al-Wadi et al, 2022, International Conference of Chemistry and Petrochemical Techniques (ICCPT) CrossRef
10. Radiation and Androgen Deprivation Therapy With or Without Docetaxel in the Management of Nonmetastatic Unfavorable-Risk Prostate Cancer: A Prospective Randomized Trial
    Anthony V. D'Amico et al, 2021, Journal of Clinical Oncology CrossRef
11. Androgenic modulation of AR-Vs
    Ana Caroline Hillebrand et al, 2018, Endocrine CrossRef
12. Preoperative endogenous total testosterone predicts prostate cancer progression: results in 580 consecutive patients treated with robot assisted radical prostatectomy for clinically localized disease
    Antonio Benito Porcaro et al, 2023, International Urology and Nephrology CrossRef
13. Challenging the Prevailing Therapeutic Dogma for Prostate Cancer: The Case for an Overlap Syndrome
    Christopher J. Logothetis et al, 2024, European Urology CrossRef
14. The Role of Omentin-1 in Cancers Development and Progression
    Paweł Dec et al, 2023, Cancers CrossRef
15. Partners in Crime: Towards New Ways of Targeting Calcium Channels
    Lucile Noyer et al, 2019, International Journal of Molecular Sciences CrossRef
16. Positive independent association between preoperative endogenous testosterone density and tumor load density in surgical specimen of patients undergoing radical prostatectomy
    Antonio Benito Porcaro et al, 2024, Urologia Journal CrossRef
17. Low testosterone at first prostate‐specific antigen failure and assessment of risk of death in men with unfavorable‐risk prostate cancer treated on prospective clinical trials
    Katelyn M. Atkins et al, 2018, Cancer CrossRef
18. A Comprehensive Analysis of Steroid Hormones and Progression of Localized High-Risk Prostate Cancer
    Eric Lévesque et al, 2019, Cancer Epidemiology, Biomarkers & Prevention CrossRef
19. Safety of testosterone therapy in men with prostate cancer
    Abraham Morgentaler et al, 2019, Expert Opinion on Drug Safety CrossRef
20. Age 70 +/- 5 Years and Cancer-Specific Outcomes After Treatment of Localized Prostate Cancer: A Systematic Review
    Haitham Shaheen et al, 2024, International Journal of Radiation Oncology*Biology*Physics CrossRef